Centogene appoints ian rentsch as chief commercial officer and general manager - pharma

Cambridge, mass. and rostock, germany and berlin, march 09, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the appointment of ian rentsch as chief commercial officer and general manager - pharma, who will join the company on march 15, 2023.
CNTG Ratings Summary
CNTG Quant Ranking